These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 11375721)
1. Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. Bugaj JE; Achilefu S; Dorshow RB; Rajagopalan R J Biomed Opt; 2001 Apr; 6(2):122-33. PubMed ID: 11375721 [TBL] [Abstract][Full Text] [Related]
2. Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Achilefu S; Dorshow RB; Bugaj JE; Rajagopalan R Invest Radiol; 2000 Aug; 35(8):479-85. PubMed ID: 10946975 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents. Achilefu S; Jimenez HN; Dorshow RB; Bugaj JE; Webb EG; Wilhelm RR; Rajagopalan R; Johler J; Erion JL J Med Chem; 2002 May; 45(10):2003-15. PubMed ID: 11985468 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors. Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238 [TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of bombesin peptide derivatives as potential tumor imaging agents: effects of structure and composition of amino acid sequence on in vitro and in vivo characteristics. Okarvi SM; Jammaz IA Nucl Med Biol; 2012 Aug; 39(6):795-804. PubMed ID: 22381782 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor. Ma L; Yu P; Veerendra B; Rold TL; Retzloff L; Prasanphanich A; Sieckman G; Hoffman TJ; Volkert WA; Smith CJ Mol Imaging; 2007; 6(3):171-80. PubMed ID: 17532883 [TBL] [Abstract][Full Text] [Related]
9. NIR-Cyanine Dye Linker: a Promising Candidate for Isochronic Fluorescence Imaging in Molecular Cancer Diagnostics and Therapy Monitoring. Komljenovic D; Wiessler M; Waldeck W; Ehemann V; Pipkorn R; Schrenk HH; Debus J; Braun K Theranostics; 2016; 6(1):131-41. PubMed ID: 26722379 [TBL] [Abstract][Full Text] [Related]
10. Optical molecular imaging of lymph nodes using a targeted vascular contrast agent. Licha K; Debus N; Emig-Vollmer S; Hofmann B; Hasbach M; Stibenz D; Sydow S; Schirner M; Ebert B; Petzelt D; Bührer C; Semmler W; Tauber R J Biomed Opt; 2005; 10(4):41205. PubMed ID: 16178629 [TBL] [Abstract][Full Text] [Related]
11. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors. Schally AV; Nagy A Eur J Endocrinol; 1999 Jul; 141(1):1-14. PubMed ID: 10407215 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts. Santini C; Kuil J; Bunschoten A; Pool S; de Blois E; Ridwan Y; Essers J; Bernsen MR; van Leeuwen FW; de Jong M J Nucl Med; 2016 Aug; 57(8):1289-95. PubMed ID: 27127222 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors. Okarvi SM; Al Jammaz I Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867 [TBL] [Abstract][Full Text] [Related]
14. Targeting cytotoxic conjugates of somatostatin, luteinizing hormone-releasing hormone and bombesin to cancers expressing their receptors: a "smarter" chemotherapy. Nagy A; Schally AV Curr Pharm Des; 2005; 11(9):1167-80. PubMed ID: 15853664 [TBL] [Abstract][Full Text] [Related]
15. Optimization of a Protease Activated Probe for Optical Surgical Navigation. Yim JJ; Tholen M; Klaassen A; Sorger J; Bogyo M Mol Pharm; 2018 Mar; 15(3):750-758. PubMed ID: 29172524 [TBL] [Abstract][Full Text] [Related]
16. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5. Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715 [TBL] [Abstract][Full Text] [Related]
17. Probing two PESIN-indocyanine-dye-conjugates: significance of the used fluorophore. Hübner R; Benkert V; Cheng X; Wängler B; Krämer R; Wängler C J Mater Chem B; 2020 Feb; 8(6):1302-1309. PubMed ID: 31967633 [TBL] [Abstract][Full Text] [Related]
18. Early assessment of tumor response to gefitinib treatment by noninvasive optical imaging of tumor vascular endothelial growth factor expression in animal models. Liu Z; Sun X; Liu H; Ma T; Shi J; Jia B; Zhao H; Wang F J Nucl Med; 2014 May; 55(5):818-23. PubMed ID: 24639458 [TBL] [Abstract][Full Text] [Related]
19. Dual probe with fluorescent and magnetic properties for imaging solid tumor xenografts. Shan L; Wang S; Sridhar R; Bhujwalla ZM; Wang PC Mol Imaging; 2007; 6(2):85-95. PubMed ID: 17445503 [TBL] [Abstract][Full Text] [Related]
20. A fast tumor-targeting near-infrared fluorescent probe based on bombesin analog for in vivo tumor imaging. Chen H; Wan S; Zhu F; Wang C; Cui S; Du C; Ma Y; Gu Y Contrast Media Mol Imaging; 2014; 9(2):122-34. PubMed ID: 24523057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]